Novo Nordisk has introduced blockbuster body weight-loss drug Wegovy in Germany, its very first massive European current market, hoping Germans pays countless euros from pocket for any drug that public health insurance plan programs are so far barred from covering.This short article contains affiliate hyperlinks. When you click on the one-way links